Clovis Oncology, Inc. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-11-13: Form 8-K; Period of report 2012-11-12; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2012-11-05: Form 8-K; Period of report 2012-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2012-08-08: Form 8-K; Period of report 2012-08-08; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2012-06-18: Form 8-K; Period of report 2012-06-14; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2012-11-13 | 8-K | 2012-11-12 | 7.01 Regulation FD Disclosure | 7.01 On November 12, 2012, Clovis Oncology, Inc. (the “Company”) issued a press release announcing results from its LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 versus gemcitabine in metastatic pancreatic cancer. | a50475443.htm |
| 2012-11-05 | 8-K | 2012-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2012, Clovis Oncology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2012. | a50466326.htm |
| 2012-08-08 | 8-K | 2012-08-08 | 2.02 Results of Operations and Financial Condition | 2.02 On August 8, 2012, Clovis Oncology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2012. | a50369931.htm |
| 2012-06-18 | 8-K | 2012-06-14 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 The Annual Meeting of Shareholders (the “Annual Meeting”) of Clovis Oncology Inc. (the “Company”) was held on June 14, 2012. | d368609d8k.htm |
| 2012-05-08 | 8-K | 2012-05-08 | 2.02 Results of Operations and Financial Condition | 2.02 On May 8, 2012, Clovis Oncology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2012. | a50267689.htm |
| 2012-03-07 | 8-K | 2012-03-07 | 2.02 Results of Operations and Financial Condition | 2.02 On March 7, 2012, Clovis Oncology, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and year ended December 31, 2011. | a50196535.htm |